Video

What Are the Pros and Cons of Copay Cards?

Author(s):

Randi Hernandez, MS, Associate Editor/Online

In this video from the 2013 Armada Specialty Pharmacy Summit, Mark Zitter of Zitter Health Insights discusses stakeholder views on copay cards.

In this video from the 2013 Armada Specialty Pharmacy Summit, Mark Zitter of Zitter Health Insights discusses stakeholder views on copay cards.

To see more videos, please visit our Multimedia page.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Pharmacist and doctor -- Image credit: ake1150 | stock.adobe.com
Pharmacist and patient -- Image credit: Zamrznuti tonovi | stock.adobe.com
Type 1 diabetes -- Image credit: daniiD | stock.adobe.com
Related Content
Bleeding stroke brain artery, Cellular structure with intricate connections and a vibrant red nucleus, representing biological elements.
August 15th 2025

Atorvastatin Improves Outcomes, LDL-C Following Pipeline Therapy for Intracranial Aneurysms

Luke Halpern, Assistant Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
August 15th 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Sunvozertinib Brings Changes in Non-Small Cell Lung Cancer Treatment
August 15th 2025

Sunvozertinib Brings Changes in Non-Small Cell Lung Cancer Treatment

Amy C. Nieto, BS, PharmD Candidate
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
August 15th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Coffee and tea -- Image credit: yaisirichai | stock.adobe.com
August 15th 2025

Caffeine Consumption Not Associated With Chronic Kidney Disease, Study Finds

Gillian McGovern, Associate Editor
leaky gut syndrome abstract 3d illustration
August 15th 2025

Larazotide Safe, Effective in Children With COVID-19-Related MIS-C

Luke Halpern, Assistant Editor